-
Information about Project 5: Acute myeloid leukemia (AML)
ELN Recommendation for managing AML
Döhner, H., Estey, E., Grimwade, D., Amadori, S., Appelbaum, F. R., Büchner, T., ... & Bloomfield, C. D. (2017). Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert pa ...
-
Contact Persons in Project 5: Acute myeloid leukemia (AML)
Lead Participants
Name
E-mail
Organisation
Country
C. Röllig
✍
Universitätsklinikum Dresden
Germany
M.A. Sanz
✍
Fundacion Hospital Universitario "La Fe"
Spain
G. Huls
✍
VU Academic Medical Center
The Netherlands
...
-
Contact Persons in Project 5: Acute myeloid leukemia (AML)
-
Acute promyelocytic leukemia
Acute promyelocytic leukemia, commonly called APL, is due to a chromosomal (15;17) translocation.
-
AML-Contributions for the Information Letter
Articles from the Information Letter
-
AML post-remission treatment score
For patients aged 15 to 60 years with complete remission after induction therapy
-
Publications
Ades L, Chevret S, De Botton S, Thomas X, Dombret H, Beve B, Sanz M, Guerci A, Miguel JS, de la Serna J, Garo C, Stoppa AM, Reman O, Stamatoulas A, Fey M, Cahn JY, Sotto JJ, Bourhis JH, Parry A, Chomienne C, Degos L, Fenaux F.:
Outcome of acute ...
-
Dates and Meetings
-
Minutes and programs of past meetings
Minutes & Meetings
Minutes EHA Amsterdam / The Netherlands 2006
(71KB)
Joint AML/MDS WP Session , in conjunction with the symposium of the EHA, Amsterdam, June 14, 2006
Info-Flyer EHA Stockholm / Sweden 2005
(46KB)
10th Congres ...
-
Links
Acute myeloid leukemia:
http://www.asheducationbook.org/cgi/reprint/2002/1/73.pdf
Work Packages: WP05, Physicians
National Cancer Institute - Acute myeloic leukemia:
http://www.nci.nih.gov/cancerinfo/pdq/treatment/adultAML/healthprofessional/
Work Pa ...
-
Recommendations for Project 5: Acute myeloid leukemia (AML)
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Blood. 2009 Feb 26;113(9):1875-91. Epub 2008 Sep 23.
Abstract: The introduction of all-trans retinoic acid (ATRA) and, more recen ...